The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease

Genetics and Molecular Research

Volumn 12, Issue 2, 2013, Pages 1392-1398

  Simsek, S ^a   Tekes, S ^a   Oral, D ^a   Turkyilmaz, A ^a   Isik, B ^a   Isik, M R ^a   Akkoc, H ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

ACE gene; Chronic obstructive pulmonary disease; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ANGIOTENSIN I CONVERTING ENZYME GENE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE;

EID: 84876874933     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.April.25.10     Document Type: Article

References (32)

1. Ahsan A, Ram R, Baig MA and Pasha MA (2004). ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin. Biochem. 37: 1037-1040.
2. Bayram B, Kilicci C, Onlu H, Ozkurt M, et al. (2011). Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS). Gene 489: 86-88.
3. Berdeli A and Cam FS (2009). Prevalence of the angiotensin I converting enzyme gene insertion/deletion polymorphism in a healthy Turkish population. Biochem. Genet. 47: 412-420.
4. Borzyszkowska J, Stanislawska-Sachadyn A, Wirtwein M, Sobiczewski W, et al. (2012). Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. J. Appl. Genet. 53: 175-182.
5. Brice EA, Friedlander W, Bateman ED and Kirsch RE (1995). Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 107: 706-710.
6. Busquets X, MacFarlane NG, Heine-Suner D, Morla M, et al. (2007). Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2: 329-334.
7. Domingues-Montanari S, Fernandez-Cadenas I, del Rio-Espinola A, Mendioroz M, et al. (2010). The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals. Eur. J. Neurol. 17: 1390-1392.
8. Gurkan A, Emingil G, Saygan BH, Atilla G, et al. (2009). Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis. Arch. Oral Biol. 54: 337-344.
9. Harry RG, Herman-Jan P, Ann Emil MWJS, Nicholas SH, et al. (2004). ACE gene polymorphism in COPD. Am. J. Respir. Crit. Care Med. 170: 572-573.
10. Hocher B, Schlemm L, Haumann H, Jian L, et al. (2011). Offspring sex determines the impact of the maternal ACE I/D polymorphism on maternal glycaemic control during the last weeks of pregnancy. J. Renin-Angiotensin-Aldosterone Syst. 12: 254-261.
11. Hopkinson NS, Nickol AH, Payne J, Hawe E, et al. (2004). Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170: 395-399.
12. Indrajaya T (2011). The role of ACE gene polymorphism on pathogenesis of ischemic stroke. Acta Med. Indones. 43: 152-157.
13. Kanazawa H, Okamoto T, Hirata K and Yoshikawa J (2000). Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162: 1235-1238.
14. Kanazawa H, Otsuka T, Hirata K and Yoshikawa J (2002). Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 121: 697-701.
15. Lee J, Nordestgaard BG and Dahl M (2009). Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity. Respir. Med. 103: 1286-1292.
16. MacNee W (2005). Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2: 50-60.
17. Mak JC (2008). Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int. J. Tuberc. Lung Dis. 12: 368-374.
18. Marc D, Janssens W and Miravitles M (2012). Chronic obstructive pulmonary disease. Semin. Lancet. 379: 1341-1351.
19. Miller MR, Crapo R, Hankinson J, Brusasco V, et al. (2005a). General considerations for lung function testing. Eur. Respir. J. 26: 153-161.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, et al. (2005b). Standardisation of spirometry. Eur. Respir. J. 26: 319-338.
21. Namazi S, Monabati A, Ardeshir-Rouhani-Fard S and Azarpira N (2010). Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol. Carcinog. 49: 1022-1030.
22. Pabst S, Theis B, Gillissen A, Lennarz M, et al. (2009). Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. Eur. J. Med. Res. 4 (Suppl 14): 177-181.
23. Rigat B, Hubert C, Corvol P and Soubrier F (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20: 1433.
24. Selahaddin T, Birgul I, Tekin Y and Selda S (2010). Chronic Obstructive Pulmonary Disease and Paraoxonase-1 192 and 55 Gene Polymorphisms. Biotechnol. Biotechnol. 24: 1644-1647.
25. Tkacova R, Joppa P, Stancak B, Salagovic J, et al. (2005). The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD. Wien. Klin. Wochenschr. 117: 210-214.
26. Ucar G, Yildirim Z, Ataol E, Erdogan Y, et al. (1997). Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters. Life Sci. 61: 1075-1082.
27. Ueda S, Heeley RP, Lees KR, Elliott HL, et al. (1996). Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J. Mol. Endocrinol. 17: 27-30.
28. Yakut T, Karkucak M, Ursavas A, Gulten T, et al. (2010). Lack of association of ACE gene I/D polymorphism with obstructive sleep apnea syndrome in Turkish patients. Genet. Mol. Res. 9: 734-738.
29. Yaren A, Turgut S, Kursunluoglu R, Oztop I, et al. (2006). Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J. Exp. Med. 210: 109-116.
30. Yaren A, Turgut S, Kursunluoglu R, Oztop I, et al. (2007). Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J. Investig. Med. 55: 255-261.
31. Zhang X, Wang C, Dai H, Lin Y, et al. (2008). Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 13: 683-688.
32. Zhang Y, He J, Deng Y, Zhang J, et al. (2011). The insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme gene and cancer risk: a meta-analysis. BMC Med. Genet. 12: 159.